back to top
e-alerts for this Journal

The email alerts service allows anyone who registers their email address to be notified via email when new content goes online.

Recommend this Journal

Recommend this journal to your friend or library.

Submit Manuscript

Manuscripts should be submitted online through our website or as an email attachment to the editorial office at

  • Latest Articles
  • Most Viewed

Latest Articles

Human cerebral evolution and the clinical syndrome of amyotrophic lateral sclerosis

13 May 2019

ALS may be a disease that preferentially affects cerebral structures and pathways that have evolved recently in human evolution... More

Intracerebral hemorrhage outcome: A comprehensive update

11 Mar 2019

Management of patients with ICH both in the acute and chronic phases, requires health care professionals to have a comprehensiv... More

Vestibular dysfunction as cortical damage with amyotrophic lateral sclerosis

04 Feb 2019

A simple vestibular function test may be useful as a tool to objectively monitor the progression of cerebral lesions in ALS.More

Leukocyte telomere shortening in Huntington's disease

06 Dec 2018

LT begins to shorten markedly in pre-HD patients according to CAG number and increasing age, up to the values observed in HD. T... More

Mitochondrial therapeutic interventions in Alzheimer’s disease

10 Nov 2018

Recent antioxidant and enzymatic treatments used to alleviate mitochondrial dysfunction, and current applications of targeted m... More

The role of LP in NDs where there is no neuroimaging

19 Oct 2018

The main treatable causes are infections which include, acute bacterial meningitis (ABM), cryptococcal meningitis (CM), tubercu... More

Distal limb weakness phenotype of Guillain-Barré syndrome

08 Sep 2018

DL-GBS is a distinct regional phenotype of GBS, which should be differentiated from cervical myelopathy. ... More

RVCL-S and CADASIL display distinct impaired vascular function

08 Aug 2018

Endothelial dysfunction in RVCL-S and confirmed impaired vascular smooth muscle cell relaxation in CADASIL. ... More

Neurologic outcomes in pediatric cardiac arrest survivors enrolled in the THAPCA trials

13 Jul 2018

The PRCA provides a robust method for depicting neurologic outcomes after acute encephalopathy caused by CA in children. ... More

C9orf72 is essential for neurodevelopment and motility mediated by Cyclin G1

05 Jun 2018

Hexanucleotide repeat expansions in the C9orf72 gene are a common genetic cause of familial and sporadic amyotrophic lateral sc... More

Neurophysiology and neurochemistry of corticobasal syndrome

07 May 2018

Understanding of central neurophysiology and neurochemistry of CBS using TMS and functional neuroimaging techniques. ... More

Could overmedication associated with spinal injuries be treated with one more CNS drug?

08 Jun 2016

Overmedication is undoubtedly an underrated problem associated with aging and other chronic conditions such as SCI and related ... More

Spatiotemporal expression of matrix metalloproteinase-1

06 Apr 2016

MMP-1 expressed in HPCs/small hepatocytes/ capillary endothelial cells may contribute, at least in part, to the repair and rege... More

Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids: Ca

03 Mar 2016

CLIPPERS in a 48-year-old male patient with initial response to steroid therapy, subsequent relapse, and eventual recovery afte... More

Most Viewed

Aims And Scope

Journal of Neurology and Therapeutics (JNT) is an international refereed journal, which publishes high-quality original articles reporting new information on basic and clinical aspects of neurology and therapy. The wide range of topics includes clinical neurology, neurosurgery, neuroimmunology, neuropharmacology neuroinflammation, neurodegenerative disease, neuromuscular disease, white matter disease, neurometabolic disorders, neuromuscular disorders, child neurology, neuropsychiatric disorders, neurooncology, neurocritical care, and neurogenetics. The journal encourages submission of manuscripts with relevance to (but not limited to) epilepsy, headache, stroke, sleep, sensory systems, aging and dementia, and peripheral neurology, neural tube defects, movement disorders, pain, ethics and public health.

Publication of article types

Original research: primary research from any area of Neurology and Therapeutics, or Neurology and Therapeutics related/interdisciplinary area.

Case reports: reports of clinical cases that can be educational, describe a diagnostic or therapeutic dilemma, suggest an association, or present an important adverse reaction.

Editorial: to introduce and comment on major advances and developments in the field.

Methodology: present a new experimental method, test or procedure. The method described may either be completely new, or may offer a better version of an existing method. The article must describe a demonstrable advance on what is currently available. The method needs to have been well tested ideally, but not necessarily, used in a way that proves its value.

News and commentary: short, focused and opinionated articles on any subject with in the journal’s scope. These articles are usually related to a contemporary issue, such as recent research findings, and are often written by opinion of leaders invited by the editorial board. Editorial board members and section editors may write such articles to highlight hot or emerging areas of research within a given field.

Rapid communications: devoted to the publication of short papers presenting highly original and significant material.

Review: to review systematically progress and unresolved problems in the field and make suggestions for future work. Comprehensive, authoritative, descriptions of any subject within the scope of Neurology and Therapeutics journal.

Short reports: brief reports of data from original research.

Letters to the Editor: to discuss and make reply to the contributions published in JNT, or to introduce and comment on a controversial issue of general interest.

Publication frequency

All articles of JNT are posted online immediately as they are ready for publication. All articles will be assigned a DOI number (Digital Object Identifier) where they become searchable and citeable without delay.

Why publish in Journal of Neurology and Therapeutics?

  • JNT offers scientists the opportunity to publish their research rapidly in an open access medium that is freely available online to researchers worldwide.
  • Electronic submission of manuscripts.
  • Immediate publication tentatively within a month/two months of Initial submission.
  • Efficient and objective peer review with a streamlined electronic production workflow.
  • No barriers, which helps your research reach the entire scientific community worldwide.
  • Our professional staff adds further value to your paper through the copy-editing process, which minimize stylistic errors and improves readability.
  • Our professional staff continuously working to improve the search engine rankings for NobleResearch group journals.
  • Our linking program extends too many abstracting and indexing databases, library sites, and includes participation in CrossRefTM.

Peer-review process

Peer-review is commonly accepted as an essential part of scientific publication. We appreciate the time that referees devote to assessing the manuscripts we send them, which helps to ensure that NobleResearch journals publish only material of the highest quality. Peer reviewers are asked to give their opinion on a number of issues pertinent to the scientific and formal aspects of a paper, and to judge the papers on grounds of originality and urgency. All relevant information will be forwarded to the author(s). There are several types of decision possible for each article.

  • Accept manuscript without revision
  • Accept after minor or major revision
  • Submit elsewhere, if the manuscript is better suited for another journal in our group
  • Reject manuscript, if the manuscript is substandard

In addition, papers may be rejected directly by the Chief Editor if judged to be out of scope or if scientifically or formally sub-standard. When asking for revisions, reviewers have two possible goals: to ask authors to tighten their arguments based on existing data, or to identify areas where more data are needed. Even formal revision may be required if the language or formalities is sub-standard. To facilitate rapid publication, authors are given a maximum of two months for revision. After two months, revised manuscripts will be considered as new submissions.


The review process is strictly confidential and should be treated as such by reviewers. Because the author may have chosen to exclude some people from this process, no one not directly involved with the manuscript, including colleagues or other experts in the field, should be consulted by the reviewer unless such consultations have first been discussed with the professional editor.

Timely review

NobleResearch believes that an efficient editorial process that results in timely publication provides a valuable service both to authors and to the scientific community at large. We therefore request that reviewers respond promptly, usually within fourteen (14) days of receipt of a manuscript. If reviewers need more time, we request that they contact us promptly so that we can keep the authors informed and, if necessary, assign alternative reviewers.

Supplemental files

Authors may and should take advantage of the web-based nature of the publication by submitting supplemental files that include animations, software demonstrations and innovative graphics. Supplemental files will be evaluated with the manuscript as part of the peer-review process. They should not exceed 20 megabytes in size. We accept the following file formats for supplemental files: TIF (tif), JPEG (jpg), GIF (gif), Animated GIF (gif), PostScript (ps), Encapsulated PostScript (eps), Adobe Photoshop (psd), AdobePDF (pdf), Audio (au), Audio (mp3), Audio (wav), MPEG (mpg), Quicktime (avi), Quicktime (mov).


You keep the copyright of your article. You are free to print out copies of your article, email it to your colleagues and/or post it on the web. Your colleagues can use and disseminate your work without restriction for educational and scientific purposes.


Journal of Neurology and Therapeutics offers a wide range of advertising opportunities to promote your product or service. NobleResearch group reserves the right to reject any advertisement not considered suitable for publication.

For more information please contact:

Marketing Director